Linington, Christopher

5 June 2018
1939 Views

Phone: 00 44 141 330 8143
mail: c.linington@clinmed.gla.ac.uk

Chris Linington was awarded undergraduate and post graduate degrees in Biochemistry from the University of York, but subsequently developed an abiding interest in the immunobiology of multiple sclerosis while working with Professor Hartmut Wekerle in Germany.

His research focuses on understanding how immune and nervous system interactions are involved in driving the development of multiple sclerosis and other neurological diseases. He identified myelin oligodendrocyte glycoprotein as a dominant target for demyelinating autoantibodies in the central nervous system, and together with Hans Lassmann developed the concept that the development of demyelinating lesions may require both T cell and antibody-dependent effector mechanisms.

He was awarded the Sobek Research Prize for this work in 2003 and more recently identified Neurofascin as a target for autoantibody mediated axonal injury in multiple sclerosis. He is currently based at the University of Glasgow where he holds a chair in Neuroimmunology.

You may be interested

ISNI Young Time – August 15 @ 10:00 am EST
News
16 views
News
16 views

ISNI Young Time – August 15 @ 10:00 am EST

stine - 11 August 2022

Join the ISNI Young Time on Monday August 15 @ 10:00 am EST. Here is how to connect and it…

Postdoctoral positions available in neuroimmunology in Calgary, Canada
News
51 views
News
51 views

Postdoctoral positions available in neuroimmunology in Calgary, Canada

stine - 3 August 2022

The laboratory of Dr. Wee Yong (Pubmed: Yong VW or Wee Yong V) at the University of Calgary is recruiting…

ISNIYoung – Get feedback on your work!
News
72 views
News
72 views

ISNIYoung – Get feedback on your work!

stine - 22 July 2022

The ISNI Young Committee is organizing a monthly “ISNI Young Time”. The first meeting is on August 15, 2022. During…